![Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis: Molecular Therapy - Nucleic Acids Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/a6ecc079-53f2-46ad-a7b6-b5fc534996e3/gr1.jpg)
Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis: Molecular Therapy - Nucleic Acids
![Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment | Experimental & Molecular Medicine Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment | Experimental & Molecular Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs12276-020-0464-3/MediaObjects/12276_2020_464_Fig1_HTML.png)
Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment | Experimental & Molecular Medicine
![Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway - Lu - 2018 - Journal of Cellular and Molecular Medicine - Wiley Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway - Lu - 2018 - Journal of Cellular and Molecular Medicine - Wiley](https://onlinelibrary.wiley.com/cms/asset/5d2e2494-f76f-42d9-b5f4-9a75a9411171/jcmm13556-fig-0002-m.jpg)
Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway - Lu - 2018 - Journal of Cellular and Molecular Medicine - Wiley
![Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers | Nature Communications Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-19593-0/MediaObjects/41467_2020_19593_Fig1_HTML.png)